Molecular genetics of drug addiction and related co-morbidities (R01)

-Purpose. The purpose of this Funding Opportunity Announcement (FOA) issued by the National Institute on Drug Abuse and the National Institute of Mental Health, National Institutes of Health, is to solicit Research Project Grant (R01) applications from institutions/organizations that propose to identify chromosomal loci and/or genetic variation in genes and haplotypes that are associated with either increased or decreased vulnerability to, dependence on, and/or treatment response for addiction to stimulants (e.g., cocaine, amphetamine, caffeine), narcotics (e.g. opiates), nicotine, benzodiazepines, barbiturates, cannabis, hallucinogens, and/or multiple drugs of abuse and/or their associated mental co-morbidities (e.g., major depression, schizophrenia, bipolar disorder) in human beings or animal models. Similarly, there is interest in chromosomal loci and/or genetic variation in genes and haplotypes that are associated with differences in responses to treatment for addiction to drugs of abuse, and treatments for co-morbid disorders -Mechanism of Support. This FOA will utilize the NIH Research Project Grant R01 award mechanism. -Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.